These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15404067)

  • 1. Studies on Charcot-Leyden crystals.
    AYRES WW; STARKEY NM
    Blood; 1950 Mar; 5(3):254-66. PubMed ID: 15404067
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Charcot-Leyden crystals by electron microscopy.
    Carson HJ; Buschmann RJ; Weisz-Carrington P; Choi YS
    Ultrastruct Pathol; 1992; 16(4):403-11. PubMed ID: 1502737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
    Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
    Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Charcot Leyden crystals in liver cytology-A case report.
    Thakral D; Agarwal P; Saran RK; Saluja S
    Diagn Cytopathol; 2015 May; 43(5):392-4. PubMed ID: 25350873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic leukemia; report of a case with autopsy confirmation; review of the literature.
    EVANS TS; NESBIT RR
    Blood; 1949 May; 4(5):603-13. PubMed ID: 18120780
    [No Abstract]   [Full Text] [Related]  

  • 6. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
    Dvorak AM; MacGlashan DW; Warner JA; Letourneau L; Morgan ES; Lichtenstein LM; Ackerman SJ
    Clin Exp Allergy; 1997 Apr; 27(4):452-74. PubMed ID: 9146940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
    Weller PF; Goetzl EJ; Austen KF
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes.
    Takeda M; Ueki S; Yamamoto Y; Nara M; Fukuchi M; Nakayama K; Omori Y; Takahashi N; Hirokawa M
    Asia Pac Allergy; 2020 Jul; 10(3):e24. PubMed ID: 32789109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of Charcot-Leyden crystals by human basophils in sputum and peripheral blood.
    Tanabe K; Takahashi K; Maeda M; Kimura I
    Acta Med Okayama; 1993 Apr; 47(2):85-90. PubMed ID: 8506754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Leyden crystals. Formation from primate and lack of formation from nonprimate eosinophils.
    el-Hashimi W
    Am J Pathol; 1971 Nov; 65(2):311-24. PubMed ID: 5134886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Leyden crystals.
    Babb RR
    J Clin Gastroenterol; 1985 Jun; 7(3):247-8. PubMed ID: 4020083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FORMATION OF CHARCOT-LEYDEN CRYSTALS IN HUMAN EOSINOPHILS AND BASOPHILS AND STUDY OF THE COMPOSITION OF ISOLATED CRYSTALS.
    ARCHER GT; BLACKWOOD A
    J Exp Med; 1965 Jul; 122(1):173-80. PubMed ID: 14325469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ultrastructural findings of Charcot-Leyden crystals in stroma of mastocytoma.
    Lao LM; Kumakiri M; Nakagawa K; Ishida H; Ishiguro K; Yanagihara M; Ueda K
    J Dermatol Sci; 1998 Jul; 17(3):198-204. PubMed ID: 9697048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation of blood eosinophil levels to Charcot-Leyden crystals in feces].
    BRUMPT LC; HO-THI-SANG
    Sang; 1957; 28(5):479-83. PubMed ID: 13528912
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystal-storing histiocytosis due to massive accumulation of charcot-leyden crystals: a unique association producing colonic polyposis in a 78-year-old woman with eosinophilic colitis.
    Lewis JT; Candelora JN; Hogan RB; Briggs FR; Abraham SC
    Am J Surg Pathol; 2007 Mar; 31(3):481-5. PubMed ID: 17325492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
    Dvorak AM; Letourneau L; Login GR; Weller PF; Ackerman SJ
    Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils.
    Calafat J; Janssen H; Knol EF; Weller PF; Egesten A
    Eur J Haematol; 1997 Jan; 58(1):56-66. PubMed ID: 9020375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Charcot-Leyden crystals in the hypereosinophilic syndrome.
    Dincsoy HP; Burton TJ; van der Bel-Kahn JM
    Am J Clin Pathol; 1981 Feb; 75(2):236-43. PubMed ID: 6162378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of lysophospholipase activity by intact human eosinophils and their Charcot-Leyden crystals.
    Weller PF; Bach D; Austen KF
    Trans Assoc Am Physicians; 1981; 94():165-71. PubMed ID: 7344218
    [No Abstract]   [Full Text] [Related]  

  • 20. Charcot-Leyden crystals in fine needle aspiration cytology.
    Arora VK; Singh N; Bhatia A
    Acta Cytol; 1997; 41(2):409-12. PubMed ID: 9100774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.